Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Cosmo Pharmaceuticals N.V.
  6. News
  7. Summary
    COPN   NL0011832936

COSMO PHARMACEUTICALS N.V.

(COPN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Cosmo Pharmaceuticals' Endoscopy Aid Device Secures Canadian Regulatory Approval

11/17/2021 | 01:15am EST


ę MT Newswires 2021
All news about COSMO PHARMACEUTICALS N.V.
01/20Cassiopea to Delist Shares from Swiss Bourse After Takeover by Cosmo
MT
2021Cosmo Pharmaceuticals Announces Hiring of Head of Investor Relations and Senior Leaders..
EQ
2021Cosmo Pharmaceuticals N.V. Announces Executive Changes
CI
2021Cosmo Closes Public Exchange Offer For Cassiopea After Amassing 97% Stake
MT
2021Cosmo pharmaceuticals n.v. and cassiopea s.p.a announce settlement of public exchange o..
EQ
2021Cosmo pharmaceuticals n.v. and cassiopea s.p.a. publish definitive final results of pub..
EQ
2021Cosmo Pharmaceuticals Secures Over 93% Stake in Cassiopea at Tender Closing
MT
2021COSMO PHARMACEUTICALS N.V. and Cassiopea S.p.a. PUBLISH PROVISIONAL final RESULTS OF PU..
EQ
2021Cosmo Pharmaceuticals' GI Genius Device Cuts Adenoma, Polyp Miss Rate in Colonoscopy
MT
2021DETECT study shows AI assistance using GI Genius(TM) reduces missed polyp rate by nearl..
EQ
More news
Analyst Recommendations on COSMO PHARMACEUTICALS N.V.
More recommendations
Financials
Sales 2021 80,6 M 90,4 M 90,4 M
Net income 2021 52,8 M 59,3 M 59,3 M
Net cash 2021 67,4 M 75,6 M 75,6 M
P/E ratio 2021 16,6x
Yield 2021 -
Capitalization 912 M 1 029 M 1 024 M
EV / Sales 2021 10,5x
EV / Sales 2022 9,77x
Nbr of Employees 276
Free-Float 52,8%
Chart COSMO PHARMACEUTICALS N.V.
Duration : Period :
Cosmo Pharmaceuticals N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COSMO PHARMACEUTICALS N.V.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 54,17 €
Average target price 97,02 €
Spread / Average Target 79,1%
EPS Revisions
Managers and Directors
Alessandro Della ChÓ Executive Director
Niall Donnelly Chief Financial Officer
Mauro Severino Ajani Executive Chairman
Davide Malavasi Director-Qualified Person & Technical
H. Jurgen Lenz Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
COSMO PHARMACEUTICALS N.V.-14.18%1 029
JOHNSON & JOHNSON-2.01%441 302
ROCHE HOLDING AG-8.68%304 745
PFIZER, INC.-11.02%294 900
ABBVIE INC.-1.71%235 287
ELI LILLY AND COMPANY-13.31%217 093